FindTrial
Sign In

The Efficacy and Safety of Different Phlebotonic Drugs in Children With Venous Malformations

The Efficacy and Safety of Different Phlebotonic Drugs in Children With Venous Malformations: a Prospective Cohort Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05113420
Enrollment
1000
Registered
2021-11-09
Start date
2019-09-17
Completion date
2022-09-17
Last updated
2021-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children, Only, Drug Effect, Surgery, Vascular Malformations

Brief summary

The aim of this study is to evaluate the efficacy and safety of different phlebotonic drugs in children and to assess patient satisfaction after treatment.

Interventions

DRUGDetralex

Diosmin+ Hesperidin

DRUGTroxevasin

Troxerutin

Sponsors

Center for Vascular Pathology, Moscow
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to 18 Years

Inclusion criteria

venous malformation * venous malformation

Exclusion criteria

* allergy

Design outcomes

Primary

MeasureTime frameDescription
Coagulation testing1 monthCoagulation testing

Other

MeasureTime frameDescription
Satisfaction after treatment1 monthQuestionnaire

Countries

Russia

Contacts

Primary ContactEkaterina Listovskaia
listovskaya_ek@outlook.com+79032069027

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026